SDS
CofA
A convenient set consisting of seven inhibitors useful for the study of MAP Kinase signaling pathway. The seven inhibitors are: 1 mg of PD 184352 (Cat. No. 1585-1), 5 mg of PD 98059 (Cat. No. 1666-5), 1 mg of SB 203580 (Cat. No. 1712-1), 25 mg of Sorafenib (Cat. No. 1594-25), 5 mg of SP 600125 (Cat. No. 1669-5), 5 mg of U0126 (Cat. No. 1668-5), and 1 mg of ZM 336372 (Cat. No. 1789-1).
More Information
Alternate Name/Synonyms
MAP Kinase Signaling Inhibitor Panel, PathwayReady
SKU
P-2383
Chemical Name
MAP Kinase Signaling Inhibitor Panel, PathwayReady™
Chemical Formula
See under the individual product
Appearance
Lyophilized Solids
Purity
95% by HPLC
Solubility
Soluble in DMSO
Storage Temp
-20°C
THERAPEUTIC AREA
Not Available
USE
Not Available
MDL NUMBER
Not Available
CHEMACX
Not Applicable
INCHI
Not Applicable
SMILES
Not Applicable
Peptide sequence
Not Applicable
RTECS
Not Applicable
UN #'S
Not Applicable
PACKING GROUP
Not Applicable
HAZARD CLASS
Not Applicable
Handling
Protect from air and light
| Handling | Protect from air and light |
|---|---|
| UN #'S | Not Applicable |
| Packing Group | Not Applicable |
